105 related articles for article (PubMed ID: 404579)
1. [Sustained levodopa efficacy in parkinsonism. Results of a four-year long-term follow-up study (author's transl)].
Schneider E; Fischer PA; Jacobi P
Nervenarzt; 1977 Apr; 48(4):205-10. PubMed ID: 404579
[No Abstract] [Full Text] [Related]
2. [Progress in therapy of Parkinsonian syndrome].
Völler GW
Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
[No Abstract] [Full Text] [Related]
3. [Parosmia and anosmia under L-dopa therapy (author's transl)].
Neundörfer B; Valdivieso T
Nervenarzt; 1977 May; 48(5):283-4. PubMed ID: 895952
[No Abstract] [Full Text] [Related]
4. Parkinson's disease.
Lieberman AN
Compr Ther; 1986 Mar; 12(3):25-9. PubMed ID: 3486090
[No Abstract] [Full Text] [Related]
5. [Long-term levodopa syndrome. Report of a clinical case].
Bossi L; Nobili M
Arch Sci Med (Torino); 1978; 135(4):637-9. PubMed ID: 756726
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of parkinson's syndrome. New developments].
Wieck HH
Fortschr Med; 1978 Jun; 96(21):1113-6. PubMed ID: 25833
[TBL] [Abstract][Full Text] [Related]
7. [Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) (author's transl)].
Eisenlohr JJ; Gehlen W
MMW Munch Med Wochenschr; 1974 Jul; 116(28):1353-6. PubMed ID: 4212699
[No Abstract] [Full Text] [Related]
8. [Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].
Boudin G; Pepin B; Guillard A; Godlewski S; Fabiani JM; Haguenau M
Rev Neurol (Paris); 1974; 130(7-8):273-84. PubMed ID: 4217929
[No Abstract] [Full Text] [Related]
9. Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
Mondal BK; Mondal KN
Pharmatherapeutica; 1986; 4(9):571-6. PubMed ID: 3094036
[TBL] [Abstract][Full Text] [Related]
10. [Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)].
Dolezalová B; Vacek J
Cesk Psychiatr; 1976 Dec; 72(6):403-7. PubMed ID: 1000706
[No Abstract] [Full Text] [Related]
11. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
Blanchet PJ; Konitsiotis S; Chase TN
Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
[TBL] [Abstract][Full Text] [Related]
12. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
Benbir G; Ozekmekçi S; Apaydin H; Delil S; Erginöz E
Clin Neurol Neurosurg; 2006 Dec; 108(8):726-32. PubMed ID: 16564615
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of parkinsonism].
Houeland T; Slettnes O; Sjaastad O
Tidsskr Nor Laegeforen; 1977 Jan; 97(1):6-9. PubMed ID: 847669
[No Abstract] [Full Text] [Related]
14. [Levodopa and controlled release benserazide in the handling of motor fluctuations in Parkinson's disease].
Díaz F; Chaná P
Rev Med Chil; 1991 Sep; 119(9):1022-8. PubMed ID: 1845094
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results of continuous subcutaneous apomorphine pump therapy in patients with advanced Parkinson disease].
Kreczy-Kleedorfer B; Wagner M; Bösch S; Poewe W
Nervenarzt; 1993 Apr; 64(4):221-5. PubMed ID: 8506009
[No Abstract] [Full Text] [Related]
16. [Current drug treatment of parkinsonism].
Kistenev BA; Kadykov AS; Pivovarova VM
Sov Med; 1976 Nov; (11):57-61. PubMed ID: 1006394
[No Abstract] [Full Text] [Related]
17. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].
Namba S; Ishimitsu H; Nakasone S
No To Shinkei; 1980 Oct; 32(10):991-1000. PubMed ID: 6159908
[No Abstract] [Full Text] [Related]
19. Levodopa treatment of Parkinson's syndrome: past and future.
Pletscher A
Adv Neurol; 1990; 53():469-73. PubMed ID: 2239486
[No Abstract] [Full Text] [Related]
20. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
